Breaking News, Collaborations & Alliances

Charles River Bolsters Cell Therapy Platform with Akadeum’s T Cell Isolation Technology

Partnership aims to improve cell separation and increase cell viability.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories has incorporated Akadeum Life Sciences’ GMP-grade Human T Cell Leukopak Isolation Kit into its Cell Therapy Flex Program, enhancing its offerings for cell therapy development. The move aims to streamline manufacturing processes for autologous CAR-T and TCR-T therapies, addressing persistent challenges in scalability and cost. The Cell Therapy Flex Platform, initially launched as an off-the-shelf solution, provides validated protocols and automated, closed-system pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters